Hallo! Tracked shipping to Austria with Delivery Duty Paid for just €3.99  

Ship to
Austria
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: New Directions for Clinical Application & Research - Proceedings of. In Experimental Medicine and Biology)
Type
Physical Book
Publisher
Author
Year
1996
Language
English
Pages
440
Format
Hardcover
ISBN
0306452944
ISBN13
9780306452949
Edition No.
1996
Categories

Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: New Directions for Clinical Application & Research - Proceedings of. In Experimental Medicine and Biology)

John Mills (Author) · Springer · Hardcover

Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: New Directions for Clinical Application & Research - Proceedings of. In Experimental Medicine and Biology) - John Mills

Cheaper New Book Imported to Austria
Delivery: 01 Sep - 08 Sep Shipping: 13 to 17 business days.
231,34 €
Faster New Book Imported to Austria
Delivery: 19 Aug - 21 Aug Shipping: 5 to 6 business days.
315,33 €
Import costs and 10% VAT included in the price ✅
231,34 €

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: New Directions for Clinical Application & Research - Proceedings of. In Experimental Medicine and Biology) "

The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of drugs will be licensed as well. Despite this optimism, however, there is increasing evidence that antiviral-resistant strains of pathogenic viruses will be a significant problem, perhaps especially with therapy of HIV infection, and there remains a desperate need for improved drugs (with either improved efficacy or decreased toxicity, or both) for CMV and HIV infections. This book is the edited proceedings of the Fourth Triennial Conference on Antiviral Chemotherapy, held in San Francisco, in November 1994. The conference was sponsored by the University of California, San Francisco, and co-sponsored by the International Society for Antiviral Research (ISAR), the Macfarlane Burnet Centre for Medical Research in Melbourne, Australia, and the Australian National Centre for HIV Virology Research. The conference had been organized to present an overview of the field of antiviral chemotherapy.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews